Orthofix International | OFIX - Ebitda

Stock Price
12.85
Daily Change
0.13 1.02%
Monthly
8.26%
Yearly
-4.18%
Q2 Forecast
12.04

Orthofix International reported $27.88M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 19.86M 2.06M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Medtronic USD 2.93B 482M Dec/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 27.88M 2.77M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Smith & Nephew USD 796M 139M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Surmodics USD 3.43M 1.9M Jun/2025
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD -328.81M 536.43M Sep/2025
Veracyte USD 42.31M 2.58M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025